Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

RSS icon
Thumbnail

[ARTICLE] Building a Protected PCI Program: How BUMC Phoenix Is Enhancing Revascularization Outcomes One Patient Transfer at a Time

Offered in cooperation with Abiomed

To make a difference in people’s lives through excellent patient care is both mission and mantra at Banner Health.

Thumbnail

Teaming Up to Treat Pulmonary Emboli: Clotbusters Illustrates Potential of Coordinated Response Programs

At one hospital, an aggressive treatment PE treatment program has dramatically reduced mortality.

Heart failure with preserved ejection fraction is associated with worse survival after CABG

Patients with a history of heart failure had higher rates of 30-day mortality and readmission for heart failure following CABG compared with those who had no history of heart failure, according to a population-based cohort study.

Shortage of donor hearts creates issues for physicians

The shortage of donor hearts poses an ethical dilemma for doctors, NPR reports. The article mentioned that 6,950 Americans were approved for heart transplants in 2014, but only 2,250 donor hearts became available.

Providence Health Care Becomes First Canadian Center to Adopt Revolutionary HeartFlow FFRct Analysis to Assess Coronary Artery Disease

REDWOOD CITY, Calif. – July 21, 2016 – Providence Health Care has become the first center in Canada to adopt the HeartFlow® FFRct Analysis, and also first in the world to utilize the next generation version of the platform. The HeartFlow FFRct Analysis, which was recently approved by Health Canada, is a novel, non-invasive technology used by clinicians to assess their patients for coronary artery disease. 

Surgeon specialization may predict 30-day operative mortality following cardiac procedures

A surgeon’s degree of specialization helped predict 30-day operative mortality in some common cardiology procedures, according to a retrospective analysis of Medicare data.

Systematic review finds evidence is lacking for percutaneous LAA exclusion as an alternative to oral anticoagulation

A systematic review of the published literature found that there was no evidence to recommend percutaneous left atrial appendage (LAA) exclusion in patients with atrial fibrillation who are ineligible for anticoagulation.

Thumbnail

Mortality rate remains high in patients undergoing PCI for an MI following noncardiac surgery

More than 11 percent of patients who developed perioperative MI after vascular surgery and underwent MI died within 30 days of the noncardiac procedure, according to an observational study.

Displaying 1353 - 1360 of 2712

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.